Telemedicine for the Care of Hemophilia: What Do We Gain And What Do We Lose?
Your browser doesn't support HTML5 audio
Telemedicine for the Care of Hemophilia: What Do We Gain And What Do We Lose?
Telehealth options are assumed to provide added benefit to providers and patients alike, but how much do we really know and understand about telemedicine? Listen in to the latest episode of Global Hemophilia Report as our contributors share how telemedicine has potentially benefited and detracted from hemophilia care across different populations as well as what research must still be done on the rise of telehealth in hemophilia care
Contributors:
Sativa Rangarajan, Associate Professor of Clinical Haematology
Michelle Witkop, DNP, FNP-BC
Dr. Roshni Kulkarni, Professor & Former Director
Michigan State University Centers For Bleeding And Clotting Disorders
Annette von Drygalski, MD, PharmD
Senior Advisor:
Donna DiMichele, MD
Hosted by:
Patrick James Lynch
Written by:
Simantini Karve, PhD
Show Notes:
Presenting Sponsor: Sanofi
Subscribe to the Global Hemophilia Report
Connect with the Global Hemophilia Report
Global Hemophilia Report on LinkedIn
Global Hemophilia Report on Twitter
Global Hemophilia Report on Facebook
Connect with BloodStream Media: